News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Nova Biogenetics, Inc. (IBCL) Sets up Two Subsidiaries: Nova BioPharmaceuticals And Nova Specialty Chemicals


10/19/2005 5:11:11 PM

Nova BioGenetics (OTC Bulletin Board: NVBG) announces it has formed two private subsidiaries under Nova BioGenetics. The Company elected to make a clear distinction between its Biopharmaceuticals Division and its Specialty Chemicals Division by forming the two subsidiaries. The management of Biopharmaceuticals is headed by Dr. Cecil Smith as Chairman of the Board, Dr. Kevin Smith as CEO, and Mr. Jerry Smith as President. The Specialty Chemicals Division is currently being overseen by Nova BioGenetics' management.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES